Events

Just Released: New Trends in Preventive and Therapeutic Vaccine

Connie Walsh — Mon, 30 Jan 2012 10:56:51 -0500

This new Insight Pharma Report analyzes current R&D activities and commercial prospects for vaccines. Sectors covered include bacterial infections; viral infections including hepatitis, HIV, influenza, and others; autoimmune diseases, cancer, and many more. For more info, www.insightpharmareports.com

BioNetwork East: Key BioPharma Partnering Conference

Connie Walsh — Wed, 18 Jan 2012 17:38:13 -0500

BioNetwork East is an elegant and intimate retreat for BioPharma business development executives to explore opportunities in partnering & funding. Visit www.bionetworkeast.com and use code BE12Fierce to save $825 - our best offer!

CALBIO2012: Driven By Patients - Marriott Marquis

Molly Cadden — Wed, 11 Jan 2012 16:25:28 -0500

Powered by BIO One-on-One, biopharma dealmakers, VCs and foundations partner with Bay Area and SoCal companies under one roof. Reach 1500 life science professionals. Gain new perspectives for biz dev, finance, and clinical trials at 32 sessions. Keynotes by Eschenbach and Scangos. Learn more.

DCAT Week 2012

Connie Walsh — Thu, 12 Jan 2012 12:57:18 -0500

Join thousands of sourcing and sales professionals as they gather for high-level strategy meetings, networking opportunities, and education sessions on timely topics impacting the industry, including GDUFA, supply chain security, and high potency technologies. Learn more.

DCAT Week '12 Biologics Forum & Networking Reception

Connie Walsh — Thu, 12 Jan 2012 12:58:33 -0500

Representatives from the FDA, Genentech, and Pfizer will discuss the regulatory filing pathway for biosimilars, key global investment drivers for the biologic-based drug industry, and raw material related risk for biopharmaceutical-based manufacturing processes. Learn more.

Live Web Conference: Risk Management of Adventitious Agent Contamination

Molly Cadden — Thu, 19 Jan 2012 12:39:40 -0500

A key requirement for production of biopharmaceutical products is to ensure freedom from contamination by adventitious agents. In addition to compromising product safety, contamination events can result in lost product, delayed production time and added expenses for a manufacturer. Click here to register.

Connect, Collaborate, & Innovate: MassBio Annual Meeting

Molly Cadden — Fri, 13 Jan 2012 12:41:52 -0500

Join industry leaders to discuss and debate, "what will it take to re-catalyze life-science innovation?" This meeting will feature leaders of NIH, FDA, academia and industry and sessions on platform technologies, the future of personalized medicine and therapeutic area mechanisms of action. Learn more.

World Orphan Drug Congress USA 2012

Caroline Soderstrom — Tue, 07 Feb 2012 17:18:02 -0500

The World Orphan Drug Congress USA is North America's leading orphan drug conference. This forum brings together leading pharma and biotech executives to strategize about the opportunities and challenges in commercializing treatments for rare and ultra-rare diseases. The conference is co-located with the World Pediatric Drugs Congress, meaning double the networking and double the content. For more information please visit our website or call +1 646 619 1792.

Pharmaceutical Strategic Outlook

Connie Walsh — Tue, 07 Feb 2012 15:21:12 -0500

PSO is an in-depth analysis on the top issues affecting the industry, creating a dynamic three days of networking and discussion. It is an exclusive event where dealmaking decision makers can have focused, meaningful conversations about partnership opportunities and more. Register now!

Pharmaceutical Strategic Outlook

Connie Walsh — Tue, 07 Feb 2012 15:21:12 -0500

Euro-Biotech Partnering Summit

Connie Walsh — Tue, 07 Feb 2012 13:34:56 -0500

Biopharma executives will gather to discuss and debate new ways of sourcing, developing and marketing innovation. Meet senior-level business development and C-level attendees, hone your dealmaking skills at our plenary panel discussions, and discover exactly the right partner. Register Now!